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ABSTRACT: The opioid-related receptor, ORL1, is activated by the neuropeptide 
nociceptin/orphanin FQ (N/OFQ) and inhibits high-voltage activated (HVA) calcium channel 
currents (ICa) via a G-protein coupled mechanism. Endocytosis of ORL1 receptor during 
prolonged N/OFQ exposure was proposed to cause N-type voltage-gated calcium channel 
(VGCC) internalization via physical interaction between ORL1 and the N-type channel. 
However, there is no direct electrophysiological evidence for this mechanism in dorsal root 
ganglion (DRG) neurons or their central nerve terminals. The present study tested this using 
whole-cell patch clamp recordings of HVA ICa in rat DRG neurons and primary afferent 
excitatory synaptic currents (eEPSCs) in spinal cord slices. DRG neurons were classified on 
the basis of diameter, isolectin-B4 (IB4) binding and responses to capsaicin-, N/OFQ- and a 
µ-opioid agonist, DAMGO. IB4-negative neurons < 20 μm diameter were selectively 
responsive to N/OFQ as well as DAMGO. In these neurons, ORL1 desensitization by a 
supramaximal concentration of N/OFQ was not followed by a decrease in HVA ICa current 
density or proportion of whole cell HVA ICa contributed by N-type VGCC as determined 
using the N-type channel selective blocker, ω-conotoxin CVID. There was also no decrease 
in the proportion of N-type ICa  when neurons were incubated at 37°C with N/OFQ for 30 min 
prior to recording. In spinal cord slices, N/OFQ consistently inhibited eEPSCs onto dorsal 
horn neurons. As observed in DRG neurons, preincubation of slices in N/OFQ for 30 min 
produced no decrease in the proportion of eEPSCs inhibited by CVID. In conclusion, no 
internalization of the N-type VGCC occurs in either the soma or central nerve terminals of 
DRG neurons following prolonged exposure to high, desensitizing concentrations of N/OFQ. 
 
Abbreviations BSA, bovine serum albumin; CVID, ω-conotoxin CVID; DAMGO, [Tyr-D-
Ala-Gly-MePhe-Gly-ol]enkephalin; DRG, dorsal root ganglion; ORL1R, opioid receptor-like 
receptor 1; N/OFQ, nociceptin / orphanin FQ; HBS, hepes buffered saline; HVA, high-
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voltage activated; IB4, isolectin B4; ME, [Met5]-enkephalin; MOR, μ-opioid receptor; 
TRPV1, transient receptor potential channel subfamily V member 1; VGCC, voltage-gated 
calcium channel.   
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INTRODUCTION: 
The opioid-like receptor, ORL1, and its endogenous ligand, nociceptin/orphanin FQ (N/OFQ) 
comprise a signaling system closely related to, but distinct from opioid systems (Meunier et 
al., 1995; Reinscheid et al., 1995). Activation of the ORL1 receptor (ORL1R) couples to G-
protein-related signaling mechanisms including inhibition of VGCCs and activation of K-
channels (Connor et al., 1996a; Connor et al., 1996b; Larsson et al., 2000; Borgland et al., 
2001). Drugs that act on ORL1Rs have been implicated as potential therapeutics for several 
conditions, including pain (Reiss et al., 2008; Hayashi et al., 2010).  The involvement of 
N/OFQ and the ORL1R in pain modulation is complex and activation of the ORL1R has been 
implicated in both analgesia and hyperalgesia (Courteix et al., 2004; Okuda-Ashitaka et al., 
2006; Chen & Sommer, 2007). This is dependent on the distribution of the receptor, for 
example, intrathecal administration of N/OFQ is antinociceptive (Yamamoto et al., 1997) 
whilst intracerebroventricular injection appears to be pronociceptive (Meunier et al., 1995; 
Reinscheid et al., 1995).  
 
The ORL1R is expressed by sensory neurons but little is known about the expression patterns 
and selective actions on specific, potentially nociceptive subpopulations. Studies in rat using 
in situ hybridisation have reported that ORL1R mRNA is expressed mainly in medium to 
large sized rat dorsal root ganglion (DRG) neurons (Pettersson et al., 2002). However, in rat 
dorsal DRG neurons, N/OFQ selectively inhibited high voltage-activated (HVA) calcium 
channel currents (ICa) in the majority of small to medium sized neurons (< 25 µm diameter) 
but only in a small proportion of larger neurons (Beedle et al. 2004). Similarly, in mouse 
trigeminal ganglion neurons both N/OFQ and µ-opioid receptor (MOR) agonist DAMGO 
selectively inhibited HVA ICa (predominantly Cav2.2) in a large proportion (> 80%) of small 
nociceptive neurons that did not express low-voltage-activated ICa (Borgland et al., 2001). To 
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study mechanisms of antinociceptive actions of N/OFQ in rat spinal cord, we first sought to 
identify whether functional expression of ORL1Rs was enriched in a subpopulation of rat 
DRG neurons as well as their terminals in the dorsal horn of spinal cord using patch clamp 
electrophysiology in acutely isolated neurons and brain slices. We found that ORL1R 
coupling to inhibition of HVA ICa was very selective for a subpopulation of small (<20 µm 
diameter) rat DRG neurons that are isolectin-B4 (IB4) -negative and, therefore, presumably 
peptidergic (Wang et al., 1994).  Most of these neurons were also sensitive to DAMGO. 
Activation of the ORL1R also produced greater inhibition of primary afferent electrically-
evoked post-synaptic currents (eEPSCs) in lamina I of the superficial dorsal horn of the 
spinal cord, where small peptidergic fibres selectively terminate than lamina IIinner where 
nociceptive, IB4 positive fibres predominantly terminate (Braz et al., 2005). These findings 
provide a functional anatomical basis for antinociceptive actions of N/OFQ in spinal cord. 
Prolonged agonist stimulation has been reported to desensitize (Connor et al., 1996a; 
Spampinato et al., 2002) and internalize the ORL1R (Spampinato et al., 2001; Spampinato et 
al., 2002; Corbani et al., 2004). A novel mechanism of modulation ORL1R signaling was 
more recently proposed that involves co-internalisation of the ORL1R and the VGCC  α1-
subunit, Cav2.2 (Altier et al., 2006). Altier et al. (2006) reported profound co-internalisation 
of ORL1Rs and Cav2.2 after exposure to N/OFQ for up to 30 min when these were 
heterologously expressed in cell lines (Altier et al., 2006). Due to a physical interaction 
between the C-termini of the ORL1R and Cav2.2 (Beedle et al., 2004), it was reported that 
co-internalisation leads to trafficking and degradation of Cav2.2 in lysosomes, thereby 
decreasing the membrane expression of Cav2.2 (Beedle et al., 2004; Altier et al., 2006). If 
present in sensory neurons, this mechanism would be expected to reduce excitability and 
transmitter release, thereby potentially producing antinociception. However, these studies 
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(Altier et al., 2006) were performed mostly in cultured cells heterologously expressing 
ORL1R and Cav2.2 constructs. Only indirect, calcium imaging evidence for modulation in 
sensory neurons was provided to suggest that this phenomenon may occur in vivo (Altier et 
al., 2006). A more recent study further suggested that hetero-oligomers of ORL1 and MOR 
form when heterologously expressed in cell ines, and that activation of either receptor could 
drive internalization of Cav2.2 (Evans et al., 2010).   
Having identified a subpopulation of sensory neurons that very selectively express strong 
coupling of the ORL1R to Cav2.2, we sought to determine whether prolonged exposure of 
sensory neurons to a high desensitising concentration of N/OFQ could reduce Cav2.2 currents 
in small IB4-negative neurons or their nerve terminals. Although exposure to N/OFQ reliably 
desensitized ORL1R coupling to VGCC currents, prolonged incubation of DRGs in a 
supramaximal concentration of N/OFQ, or ORL1 plus MOR agonists, had no effect on HVA 
ICa density or the proportion of HVA ICa  sensitive to the highly selective Cav2.2 blocker, ω-
conotoxin CVID (Lewis et al., 2000; Lewis et al., 2012). Consistent with the results from 
DRG neurons, prolonged exposure to N/OFQ had no effect on the sensitivity of primary 
afferent eEPSCs onto lamina I or lamina IIinner dorsal horn neurons to inhibition by CVID.  
Together, these results suggest that sustained activation of the ORL1R does not down-
regulate Cav2.2 expression on the soma or nerve terminals of primary afferent neurons. 
METHODS: 
Sprague Dawley rats (3-7 weeks old males (n = 48) for DRG recordings and 16-31 days old 
males and females for spinal cord recordings (n = 41)) were used in this study. Animals were 
housed in groups of 2-4 with environmental enrichment on a 12 h/12h light dark cycle at 22 ± 
2o C, with ad libitum access to food and water. All experiments were conducted according to 
protocols approved by the Animals Ethics Committee of the University of Sydney, Sydney, 
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NSW, Australia, which complies with the National Health and Medical Research Council 
“Australian code of practice for the care and use of animals for scientific purposes”. 
Isolated DRG neuron preparation 
Rats were anaesthetized with isofluorane (4% in air) and decapitated. Dorsal root ganglia 
(spinal levels L3-L5) were removed and placed in ice-cold Hepes buffered saline (HBS) 
containing (mM): NaCl, 154; KCl, 2.5; CaCl2, 2.5; MgCl2, 1.5; Hepes, 10; glucose, 10; pH 
7.2 (NaOH), 330 ± 5 mosmol/l. Cells were prepared using the methods outlined in Borgland 
et al. (2001). Briefly, ganglia were cut up with iridectomy scissors and incubated at 37° C for 
15 min in oxygenated HBS containing 3 mg/ml collagenase and for 25 min in oxygenated 
HBS containing 1 mg/ml papain. The digestion was terminated with addition of HBS 
containing 1 mg/ml bovine serum albumin (BSA) and 1 mg/ml trypsin inhibitor. Ganglia 
were washed free of enzyme and enzyme inhibitors with room-temperature HBS. Cells were 
dispersed by gentle trituration through decreasing bore, silanized Pasteur pipettes with fire-
polished tips. The cells were plated onto plastic culture dishes and kept at room temperature 
in HBS. Cells remained viable for up to 10 h after dissociation. 
Spinal cord slice preparation 
Rats were anaesthetized with isofluorane (4% in air), decapitated and the lumbar region of 
the spinal cord was removed as previously described (Rycroft et al., 2007; Vikman et al., 
2008). Transverse spinal cord slices (350 µm) were cut on a vibratome (Leica, VT1000) in an 
ice-cold solution of the following composition (in mM): 100 sucrose, 63 NaCl, 2.5 KCl, 1.2 
NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 25 glucose, and 2.5 NaHCO3. Slices were maintained at 32° 
C in a submerged chamber containing physiological saline solution (ACSF) consisting of (in 
mM): 125 NaCl, 2.5 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 25 glucose, and 2.5 NaHCO3 
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(pH 7.4, osmolarity 305-310 mOsm/l), which was equilibrated with 95% O2 and 5% CO2. 
The slices were then transferred to a recording chamber and superfused continuously (2 
ml/min) with ACSF. Experiments were performed at 32 °C.  
Visualization of IB4 binding 
Isolated DRG cells were pre-treated with 1 μg/ml Alexa Fluor 488 -conjugated Bandeiraea 
simplicifolia IB4 (Invitrogen) for 10 min at 22–24° C as previously described (Borgland et 
al., 2001). Neurons were washed with HBS for 5 min before fluorescence was examined on 
the inverted microscope (Olympus, IX50) used for patch-clamp recordings. 
Electrophysiological recording from DRG neurons 
Ionic currents from rat DRG neurons were recorded in the whole-cell configuration of the 
patch-clamp method at room temperature (22–24 °C). Dishes were continually perfused with 
HBS. For isolating ICa, the extracellular solution contained (mM): tetraethylammonium 
chloride (TEACl), 140; CsCl, 2.5; CaCl2, 2.5; Hepes, 10; MgCl2, 1; glucose, 10; pH 7.2 
(CsOH) 330 ± 5 mosmol/l. The intracellular pipette solution contained (in mM): CsCl, 120; 
Hepes, 10; EGTA, 10; CaCl2, 2; MgATP, 5; Na2GTP, 0.2; NaCl, 5; pH 7.3 (CsOH); 285 ± 5 
mosmol/l. Recordings were made using an EPC-9 patch-clamp amplifier and corresponding 
PULSE software from HEKA Electronik (Lambrecht/Pfalz, Germany). Currents were 
sampled at 20–50 kHz and recorded on hard disk for later analysis. Patch pipettes were pulled 
from borosilicate glass (AM Systems, Everett, WA, USA). The pipette input resistance 
ranged between 1.5 and 2.5 MΩ. The capacitance of individual cells was estimated by 
PULSE software by fitting an exponential to current responses to small rectangular voltage 
pulses and ranged between 10 and 50 pF. Series resistance was between 3 and 10 MΩ. Series 
resistance compensation of between 70% and 80% was used in all experiments. Capacitance 
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transients were compensated automatically using a built-in procedure of the HEKA amplifier. 
Leak current was subtracted online using a P/8 protocol. Liquid junction potential of 4 mV 
was not corrected for. 
Cell diameter was estimated from membrane capacitance measurement derived by PULSE 
software from the voltage-clamp charging curve.  As previously reported (Borgland et al., 
2001), directly visualized diameter (using a micrometer graticule) was highly correlated with 
diameter calculated from cell capacitance using the relationship assuming a specific 
membrane capacitance of 0.9 µF/cm2. All cell diameter data are reported from the latter. 
Peak HVA ICa in each cell was determined by stepping the membrane potential from a 
holding potential of -90 mV to between -60 and 30 mV, for 10 ms, in 10 mV increments. 
Following this procedure, the test current was evoked (-80- to 0 mV) every 30 s and 
monitored for current stability before drugs were applied.  
Cells were exposed to drugs via a series of flow pipes positioned above the cells. The 
inhibition by drugs was quantified by measuring the current isochronically from the peak of 
the control current in the presence and absence of the drug.  
Electrophysiological recording from spinal cord slices 
Lamina I was visualised using infra-red Nomarski optics and presumed NK1-positive 
neurons were selected for experiments based on size and shape of the cell soma (Rycroft et 
al., 2007). Lamina II was identified as the translucent area adjacent to lamina I. Dorsal cells 
in this region were considered in lamina IIo and those ventral and adjacent to the less 
translucent lamina III considered lamina IIi.  Whole-cell voltage-clamp recordings (holding 
potential -74 mV) of synaptic currents were made using a Digidata 1322A and a Multiclamp 
700B amplifier (both from Molecular Devices, California, USA). Patch electrodes with a 
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resistance of 2-4 MΩ were filled with a solution consisting the following (in mM): 113 
CsGluconate, 10 EGTA, 10 HEPES, 17.5 CsCl, 8 NaCl2, 3 QX-314, 0.2 % (w/v) biocytin, 2 
MgATP and 0.3 NaGTP, pH 7.2 (osmolarity, 280–290 mOsm/L). Series resistance (≤ 15 
MΩ) was compensated by 80% and continuously monitored during experiments. Liquid 
junction potentials of -14 mV were not corrected for. Recordings were low-pass filtered at 4-
6 kHz, sampled at 10 kHz and analysed off-line using Axograph X (Axograph Scientific, 
Australia). A bipolar tungsten electrode (FHC, ME, USA) was carefully placed in the dorsal 
root entry zone to ensure stimulation of primary afferent terminals and electrically evoked 
excitatory postsynaptic currents (eEPSCs) were recorded (0.01 Hz, 2–30 V, 100 μs). To 
isolate eEPSCs, all experiments were performed in the presence of strychnine (5 μM) and 
picrotoxin (100 μM) to block glycine and GABAA mediated synaptic currents. Unless 
otherwise stated, eEPSCs were quantified by averaging a minimum of 20 consecutive 
responses for each condition. Only evoked currents with a clear first peak and no latency 
jitter were measured and included in the analysis to avoid contamination from polysynaptic 
events.  
Data analysis 
All data are expressed as the mean ± S.E.M. unless otherwise indicated. Concentration–
response data were pooled for each group and fitted to a logistic equation with a minimum 
constrained to zero using the software package GraphPad Prism v. 3. Where noted, 
significant differences between means were tested using paired or unpaired two-tailed 
Student’s t tests, or when more than two groups were included, one factor ANOVA, followed 
by Dunnett’s test. Differences between frequency data were tested using χ2 tests.  
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Drugs and chemicals 
DAMGO ([Tyr-D-Ala-Gly-MePhe-Gly-ol]enkephalin), [Met5]-enkephalin, N/OFQ (Phe-Gly-
Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln), bovine serum albumin, 
trypsin inhibitor (chicken egg white ovomucoid, Type II-O) and CdCl2 were from Sigma-
Aldrich. ω-Conotoxin CVID was provided by RJ Lewis, Institute of Molecular Biology, 
University of Queensland. Capsaicin was from Tocris Cookson (Bristol, UK). Papain and 
collagenase were from Worthington Biochemical Corporation (Freehold, NJ, USA). Alexa 
Fluor 488-IB4 was from Invitrogen.  
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RESULTS 
 
Categorization of rat DRG neurons 
 
Rat DRG neurons were categorised on the basis of several criteria in order to identify 
whether or not a defined subpopulation of DRG neurons selectively responds to N/OFQ (Fig. 
1). The criteria correlated with responses to a supramaximal concentration (see below) of 
N/OFQ (300 nM, Fig 1 C, E, F, G) included soma diameter (Fig 1 F,G), whether or not they 
were IB4-negative (presumed peptidergic) or IB4-positive (presumed non-peptidergic) using 
preincubation with AlexaFluor 488 conjugated IB4 (Fig. 1A), responsiveness to TRPV1 
receptor agonist capsaicin (500 nM; Fig. 1 B, G), as well as the MOR agonist, DAMGO (1 
µM, Fig. 1D, E).Complete current-voltage relationships were also determined in the absence 
or presence of N/OFQ (data not shown). As previously reported, N/OFQ did not affect the 
voltage-dependence of HVA ICa (Borgland et al., 2001). 
 
In order to demonstrate the voltage-dependence of G-protein inhibition of VGCCs by 
N/OFQ, we used a prepulse protocol (data not shown). In these experiments, HVA Ica was 
evoked by two test steps to 0 mV, separated by 190 ms. The second test step was preceded by 
a conditioning step to +120 mV for 70 ms. In the presence of 300 nM N/OFQ, the amplitude 
evoked by the first test step was less than the amplitude evoked by the second test step that 
followed the conditioning step, due to the voltage-dependent relief of G-protein inhibition. 
This voltage-dependent relief was also previously observed in trigeminal ganglion neurons 
(Borgland et al., 2001). In all subsequent experiments, peak HVA ICa was elicited by a single 
depolarising step from -80 mV to 0 mV. A subpopulation of DRG neurons not labeled by IB4 
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were found to be highly responsive to both N/OFQ and DAMGO. This was correlated 
strongly with the soma diameter as discussed in detail below.  
 
N/OFQ selectively inhibits HVA ICa in a subpopulation of small IB4-negative 
(peptidergic) DRG neurons 
 
Neurons were defined as N/OFQ sensitive if they showed a reversible inhibition of HVA ICa 
of greater than 10% when exposed to maximally effective concentrations of N/OFQ (300 
nM) (Fig. 1C,E). Since size is a good indicator of function in DRG neurons, cells were 
categorised into three groups based on soma diameter as follows : < 20 μm (small), 20-30 μm 
(medium), and > 30 μm (large). In all three groups, neither TRPV1-positive nor -negative 
neurons emerged as N/OFQ-responsive populations (Fig. 1G). Responsiveness to N/OFQ was 
greatest among small neurons, with 71% of neurons (27 out of 38) displaying inhibition of ICa 
greater than 10%, followed by 39% of medium sized (17 out of 44) then 24% of large (4 out 
of 17) neurons (χ2 = 13.70, P = 0.001).  Most neurons that responded to N/OFQ also 
responded to the MOR agonist, DAMGO (1 μM, Fig 1 D,E). 
 
Responsiveness to N/OFQ in the three neuronal size categories was then examined on the 
basis of IB4-binding (IB4+ or IB4-; Fig. 1F), responsiveness to capsaicin (TRPV1+ or 
TRPV1-; Fig. 1G) and DAMGO. Responsiveness to N/OFQ was enriched in small IB4-
negative neurons. N/OFQ (300 nM) produced  51 ± 3% inhibition of  HVA ICa  in 85% (17 
out of 20) of small diameter (< 20μm) IB4- neurons (Fig. 2B). Furthermore, 88% (15 out of 
17) of small neurons that responded to N/OFQ were also responsive to DAMGO although 
DAMGO usually produced less inhibition of HVA ICa than N/OFQ (34 ± 4%, n = 15) in this 
population of neurons (Fig. 2B). The native peptide agonist, [Met5]-enkephalin (10 µM) 
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produced similar inhibition to that produced by DAMGO (data not shown). This group of 
small, presumed peptidergic neurons was thus identified as a distinct population of DRG 
neurons highly responsive to both N/OFQ and DAMGO. In contrast to the N/OFQ responsive 
population of small presumed peptidergic neurons, N/OFQ inhibited HVA ICa in only 30% (3 
out of 10) of small IB4+ neurons (Fig. 2). All 3 of these responsive small IB4+ neurons also 
responded to DAMGO. In neurons > 20 μm diameter, there was no distinct correlation 
between IB4-binding and response to N/OFQ, perhaps because very few medium to large 
sized neurons were IB4+ (6 out of 47), as reported elsewhere (Gerke & Plenderleith, 2001). 
Responses to capsaicin did not distinguish responses to N/OFQ for any sized DRG neurons. 
Similar proportions of N/OFQ responsive neurons were found among TRPV1+ and TRPV1- 
neurons of all sizes (Fig 1G).  
 
ORL1R desensitization is not correlated with a decrease in N-type ICa 
 
Experiments to investigate whether or not prolonged application of a supramaximal 
concentration of N/OFQ reduced surface expression of the N-type VGCCs were carried out 
in DRG neurons that were less than 20 μm diameter and did not exhibit IB4-binding. 
Application of increasing concentrations of N/OFQ to this subpopulation of DRG neurons 
produced a maximal effect at concentrations between 30 and 100 nM (Fig. 3A).300 nM 
N/OFQ was therefore considered supramaximal.  ω-Conotoxin CVID (CVID) is a highly 
selective antagonist of N-type VGCCs (Lewis et al., 2012). Internalization of Cav2.2 
channels, if it occurs during desensitization of the ORL1R should be reflected as a reduction 
in the proportion of HVA ICa sensitive to inhibition by a maximal concentration of CVID. As 
shown in Fig. 3B, a concentration of 300 nM of CVID was sufficient to produce maximal 
inhibition.  
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ORL1R desensitisation was determined in small, IB4-negative DRG neurons during 
prolonged exposure (10 min) to a supramaximal concentration of N/OFQ (300 
nM).Desensitization was measured both by the decline in response to the supramaximal 
concentration as well as the response to a submaximal, probe concentration of N/OFQ before 
and after the 10 min application of 300 nM N/OFQ. As previously discussed for 
desensitization of MOR in neurons, the decline in response to a submaximal concentration of 
agonist provides a sensitive index of desensitization (Connor et al., 2004).  
 
Pronounced ORL1 desensitization occurred in all neurons tested (Fig. 4A), when measured 
either as the decline in response to the supramaximal, or the submaximal, probe concentration 
of N/OFQ. The amplitude of inhibition by 300 nM N/OFQ decreased significantly from 44± 
3% initially to 25 ± 2% after 10 min (n = 5, P = 0.0004, paired t-test). Inhibition of HVA ICa  
by 10 nM N/OFQ also decreased significantly from 28 ± 6% to 7 ± 2% (P = 0.006). These 
results suggest that exposure to a supramaximal concentration of N/OFQ for 10 min produces 
regulation (desensitization) of ORL1R function under our recording conditions.  
 
Although ORL1R desensitization was readily observed, exposure of small, IB4-negative 
DRG neurons to a supramaximal concentration of N/OFQ (300 nM) for 10 min affected 
neither overall HVA ICa density nor the proportion of N-type channels susceptible to 
inhibition by CVID. To control for rundown of HVA ICa, recordings were made for a similar 
duration in control neurons (20-30 min) before applying 300 nM CVID. Over the total 
duration of recording prior to application of CVID, similar rundown was observed in N/OFQ-
exposed (87 ± 5.5% of initial ICa, n = 5) and control (88 ± 7% of initial ICa, n = 5) neurons. 
The duration of recordings over which rundown was determined did not differ between 
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groups (25.1 ± 1.6 min, n = 5 for control, 25.7 ± 2 min, n = 5 for N/OFQ-exposed).  In the 
same group of neurons, HVA ICa density was not significantly affected after washout from 10 
min exposure to N/OFQ (127 ± 24 pA/pF in treated versus 172 ± 39 pA/pF in control 
neurons; P = 0.36). There was also no significant difference in the proportion of HVA ICa 
susceptible to inhibition by CVID (Fig. 4B). 
 
 
Prolonged incubation with N/OFQ or N/OFQ plus met-enkephalin did not decrease  N-
type HVA ICa  
 
The failure to observe a reduction in N-type HVA ICa during whole-cell patch-clamp 
recordings might have been due to incubation temperature (22–24 °C), duration of N/OFQ 
exposure (10 min) or the whole-cell procedure per se.  To test this, DRG neurons were 
incubated at 37⁰ C with either N/OFQ (300 nM) or N/OFQ (300 nM) plus met-enkephalin 
(ME, 10 μM) for 30 min immediately prior to patch-clamp recording. Following incubation, 
the culture dishes containing the neurons were perfused with HBS at room temperature for 5 
min before recordings were made. HVA ICa density and susceptibility to inhibition by CVID 
was then used to determine the proportion of N-type currents. Control neurons were 
incubated at 37⁰ C for 30 min in the absence of either agonist. Incubation in N/OFQ or 
N/OFQ plus ME did not reduce HVA ICa density, which was 112 ± 11 (n = 16), 133 ± 9 (n = 
13) and 174 ± 27 (n = 6) pA/pF in control, N/OFQ and N/OFQ plus ME exposed neurons, 
respectively. If anything there was a small increase in HVA ICa density in cells exposed to 
N/OFQ plus ME (P = 0.02, Dunnett’s post-hoc test). There was also no decrease in the 
proportion of HVA ICa susceptible to inhibition by CVID (Fig. 4C). Therefore, prolonged 
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incubation with ORL1R or MOR agonists did not produce any decrease in the N-type HVA 
ICa in rat DRG neurons.   
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Incubation with N/OFQ does not reduce the contribution of N-type HVA ICa to primary 
afferent synapses in spinal dorsal horn 
 
Calcium influx through N-type VGCCs contributes substantially to neurotransmitter release 
at primary afferent synapses in the spinal cord dorsal horn (Heinke et al., 2004; Rycroft et al., 
2007) and N/OFQ directly inhibits neurotransmitter release at the same synapses, at least 
partly via inhibition of N-type HVA ICa (Liebel et al., 1997). The possibility that N/OFQ 
downregulates Cav2.2 on primary afferent synapses was therefore examined in spinal cord 
slices. As reported elsewhere (Liebel et al., 1997), N/OFQ (10 µM) reduced the primary 
afferent eEPSC amplitude in all neurons tested (Fig. 5A). Higher concentrations of both 
N/OFQ and CVID were used in the slice experiments in order to compensate for peptidase 
activity, as previously reported in spinal tissue (Suder et al., 1999). Interestingly, the 
inhibitory effect of N/OFQ was significantly larger in lamina I neurons where peptidergic 
afferents (IB4-negative) predominantly terminate (Braz et al., 2005) compared to lamina 
IIinner neurons where IB4-positive fibres terminate (P= 0.025).  
 
Spinal cord slices were then incubated at 37⁰ C with N/OFQ (10 µM) or ACSF for 30 
minutes to determine whether activation of ORL1Rs in primary afferent nerve terminals 
could internalize Cav2.2. After washout of N/OFQ for at least 20 min the effect of CVID 
(1μM) on eEPSCs was determined (Fig 5B). There was no significant difference in the effect 
of CVID on evoked EPSC amplitude in spinal cord slices incubated with N/OFQ compared to 
those incubated with vehicle (Fig 5C) in either lamina I or lamina IIinner. 
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DISCUSSION 
 
This study has characterised a distinct subpopulation of rat sensory neurons that is highly 
responsive to N/OFQ and MOR agonists, and is IB4-negative and smaller than 20 μm in 
diameter.  A large proportion of these neurons presumably represent small nociceptive 
peptidergic sensory neurons (e.g. Kitchener et al., 1993; Gerke and Plenderleith, 2004). 
Previous studies have reported varied distribution of ORL1R in sensory neurons.  An in situ 
hybridisation study reported ORL1R mRNA expression in medium to rat large DRG neurons 
(Pettersson et al., 2002). Immunohistochemical studies in rat  have reported enrichment of 
ORL1R-like immunoreactivity in small to medium sized DRG neurons (Chen and Sommer, 
2006) or have found little selective localization at all (Monteillet-Agius et al., 1998; Altier et 
al., 2006). Previous physiological studies have also reported modest enrichment of 
responsiveness to N/OFQ in small to medium sized rat DRG neurons (Beedle et al., 2004) 
and similar enrichment was found in small mouse trigeminal ganglion neurons (Borgland et 
al., 2001). It is unlikely that the preincubation of isolated DRG neurons in IB4 affected the 
classification of subtypes because this procedure has been reported to have no effect on 
calcium currents or the actions of opioids on labelled DRG neurons (Wu and Pan, 2004; Wu 
et al., 2004). 
 
The present identification of a subpopulation of small IB4-negative DRG neurons highly 
responsive to N/OFQ is of interest because the role of ORL1R in nociceptive and sensory 
processing remains unclear (Zeilhofer and Calò, 2003; Lambert, 2008). It has previously been 
reported that peptidergic and non-peptidergic neurons are involved in parallel pain pathways 
(Braz et al., 2005). IB4+ neurons were found to be nociceptive and project preferentially to 
lamina IIinner of the dorsal horn, whilst IB4-negative neurons were found to synapse onto 
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lamina I projection neurons (Kitchener et al., 1993; Gerke and Plenderleith, 2004). These two 
regions of the spinal cord then project to different supraspinal regions involved in processing 
pain (Braz et al., 2005). Furthermore, these two populations of neurons receive sensory 
information preferentially from different targets; IB4+ neurons receive mostly cutaneous 
input and peptidergic, IB4-negative neurons predominantly innervate muscle and viscera 
(Plenderleith & Snow, 1993; Wang et al., 1998). The present findings therefore suggest a 
preferential role of the ORL1R-N/OFQ system in peptidergic sensory pathways. This is 
supported by the findings of significantly greater inhibition of eEPSCs by N/OFQ in lamina I, 
which is preferentially innervated by peptidergic (IB4-negative) primary afferent fibres than 
lamina IIinner where IB4-positive fibres preferentially terminate (Kitchener et al., 1993; Braz 
et al., 2005).  
 
By identifying a highly selective subpopulation of DRG neurons with > 80% of cells highly 
responsive to N/OFQ, it was possible to test whether activation of this receptor 
downregulates Cav2.2 in native neurons as has been reported in cultured cells (Altier et al., 
2006; Evans et al., 2010). This was achieved by direct measurement of HVA ICa density in 
small, IB4-negative DRG neurons, as well sensitivity to the highly selective N-type VGCC 
blocker, CVID in these neurons and primary afferent terminals (Lewis et al., 2000; Rycroft et 
al., 2007; Lewis et al., 2012). Although many previous studies have used ω-conotoxins 
GVIA or MVIIA as specific N-type VGCC inhibitors, we chose CVID for its higher 
selectivity for Cav2.2 than other ω-conotoxins, as well as irreversibility of inhibition (Lewis 
et al., 2000; Lewis et al., 2012). Furthermore, our previous study demonstrated a robust and 
reproducible inhibitory effect of CVID on eEPSCs recorded in spinal cord that did not differ 
from MVIIA (Rycroft et al., 2007).  In the present study, no functional evidence was found 
for internalisation of the N-type VGCC in DRG cell bodies or their nerve terminals in the 
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dorsal horn. Previous studies utilised imaging and electrophysiological techniques in tsA-201 
cell line overexpressing both ORL1 and Cav2.2 (Altier et al., 2006; Evans et al., 2010). 
However, in native DRG neurons, only imaging studies were performed (Altier et al., 2006). 
Inability to test this electrophysiologically was presumably due to the lack of information 
regarding ORL1R (and MOR) expression in different populations of sensory neurons. The 
present study has overcome this limitation by developing criteria to select DRG neurons that 
express highly effective coupling of ORL1 to HVA ICa in nearly all neurons. Small IB4-
negative DRG neurons also express a large proportion of Cav2.2, (Figure 3 and 4) as reported 
elsewhwere (Wu & Pan, 2004). Using this approach, no evidence could be found for either a 
reduced VGCC current density or proportion of N-type channels contributing to HVA ICa 
after prolonged exposure to high concentrations of N/OFQ. Although these findings are at 
odds with the findings of Altier et al. (2006) and Evans et al. (2010), whole-cell patch-clamp 
recording is arguably the most sensitive and reliable method for determing a functional 
change in surface expression of VGCC current density and, using selective channel toxins, 
determining changes in VGCC subtypes. 
 
Exposure of small IB4-negative DRG neurons to a supramaximal concentration of N/OFQ 
while continuously monitoring HVA ICa at room temperature could be criticized because the 
experiment was performed for 10 min at room temperature, which might inhibit endocytosis. 
Alternatively or additionally, diffusion of a critical intracellular mediator into the patch 
pipette could have impaired endocytosis of Cav2.2.  
However, this experiment did establish that exposure to a high concentration of N/OFQ 
reliably produced functional desensitization of ORL1R, which is closely related to 
endocytosis for many GPCRs (e.g. Dang and Christie 2012). It might be expected that 
recovery of ORL1R function after desensitization would be very prolonged due to 
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endocytosis and recycling or degradation. The time-course for resensitization of ORL1R is 
unknown but if it resembles related opioid receptors would require more than 60 min for 
complete recovery of function (Dang and Williams, 2004; Dang et al., 2011; Quillinan et al., 
2011) which would not be feasible to study by examining modulation of ICa in DRG neurons.   
 
These potential limitations would not apply to prolonged (30 min) pre-incubation of DRG 
neurons at 37o C in N/OFQ or N/OFQ plus met-enkephalin, which also produced no 
reduction in VGCC current density or proportion of N-type HVA ICa. It is most unlikely the 
calcium channel expression was restored  during the brief recovery period between 
termination of preincubation in N/OFQ and determination of HVA ICa current density 
because Altier et al. (2006) reported in tsA cells that endocytosis of Cav2.2 was followed by 
targeting for lysosomal degration of the channel. 
 
This study also found no evidence for downregulation of Cav2.2 following prolonged N/OFQ 
incubation in nerve terminals of DRG neurons in spinal cord slices. This is especially 
relevant as the N-type VGCC, along with the P/Q-type, is responsible for triggering 
neurotransmitter release and is highly localised on DRG nerve terminals found in the dorsal 
horn of spinal cord (Heinke et al., 2004).  The proportion of inhibition of primary afferent 
eEPSCs found here using CVID was also consistent with the inhibition reported using CVID, 
MVIIA (Rycroft et al., 2007) or GVIA at C-fibre afferents (Heinke et al., 2004).  
 
It is difficult to reconcile the present findings with those of Altier et al. (2006), particularly in 
DRG neurons. It is possible that endocytosis and downregulation of Cav2.2 is mediated by 
activation of ORL1 under our conditions but only in a neuronal subpopulation we did not 
record from, i.e. IB4- positive or larger neurons. If this is the case, then the internalisation 
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mechanism is not expressed by small peptidergic neurons or any primary afferent nerve 
terminals. We also cannot rule out the possibility that the internalization mechanism, if 
present, cannot be detected in acutely isolated neurons and spinal cord slices. However Altier 
et al. (2006) also presented correlative immunohistochemical evidence for Cav2.2 
internalization in acutely isolated DRG neurons, so this is an unlikely reason for the 
discrepancy. It is also possible, but seems unlikely, that Cav2.2 internalization and 
degradation did occur in our experiments but was balanced by an equally increased rate of de 
novo insertion of N-type channels into the surface membrane. A potential control for this in 
future studies in cell culture might be prolonged incubation (~40 hours) in gabapentin which 
disrupts trafficking of the channel to the membrane (Hendrich et al., 2008).  
 
In conclusion, the present study has identified a subpopulation of rat small IB4-negative DRG 
neurons that project to the superficial dorsal horn of the spinal cord and are very responsive 
to both N/OFQ and opioid agonists. However, no evidence was found for a previously 
proposed prolonged down-regulation of N-type VGCCs following exposure to high 
concentrations of N/OFQ in these neurons or their central nerve terminals in spinal cord 
slices. Downregulation of N-type VGCCs following exposure to high concentrations of 
N/OFQ therefore appears to be of no physiological significance in native sensory neurons. 
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Figure 1. Characterisation of DRG neuron phenotypes 
A,  representative example of living DRG neurons exhibiting IB4-binding. The neuron 
indicated by the arrows is IB4+ (non-peptidergic) while the others are IB4-negative 
(peptidergic). B, representative current trace from a TRPV1+ neuron in the presence and 
absence of capsaicin (500 nM) during a continuous ramp from +30 mV to -60 mV of 1 s in 
duration. C,D, representative high-voltage activated ICa before and after application of  
N/OFQ (300 nM) and DAMGO (1μM). E, ICa amplitude as a percentage of total HVA ICa 
indicating inhibition and recovery from N/OFQ (300 nM) and DAMGO (1μM). F, G, 
percentage of neurons responsive to N/OFQ when categorised on the basis of size, IB4-
binding and responsiveness to capsaicin (TRPV1+ or -). Note that 85% of IB4-negative 
neurons with soma diameter smaller than 20 μm are responsive to N/OFQ (P = 0.003, χ2 = 
9.08). The total numbers of neurons tested in each category are shown within bars. 
 
Figure 2 
A, scatter-plot of soma size vs. percentage of inhibition of HVA ICa by N/OFQ. Most 
N/OFQ-responsive neurons were smaller than 30 μm. Both IB4+ and IB4- cells showed a 
response to N/OFQ overall. As highlighted by the box, responsiveness to N/OFQ was 
concentrated in small IB4-negative neurons. B, scatter-plot showing percentage of HVA Ica 
inhibition by DAMGO vs. N/OFQ for neurons smaller than 20 μm. As highlighted by the 
box, almost all IB4-negative neurons responded to both N/OFQ and DAMGO compared to 
IB4+ neurons. Subsequent experiments in this study were performed on this population. C,D, 
scatter-plot showing percentage of HVA ICa inhibition by DAMGO vs. N/OFQ for neurons 
between 20 to 30 μm diameter and greater than 30 μm respectively. No distinct N/OFQ-
responsive subpopulation was seen in these groups. 
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Figure 3 
Concentration-response curves for A, N/OFQ and B, CVID in IB4- neurons smaller than 20 
μm (n = 3-10 cells per data point). Maximal effects were observed at 300 nM for both N/OFQ 
and CVID, which was the concentration used in the subsequent experiments. 
 
Figure 4 
A, representative time plot of ORL1R desensitisation in IB4- DRG neurons smaller than 20 
μm. 10 nM N/OFQ was used as a probe concentration and 300 nM N/OFQ as a 
supramaximal desensitising concentration. Note the attenuated response to the probe 
concentration following a 10 min exposure to 300 nM N/OFQ. Following recovery of ICa 
after washout of N/OFQ, 300 nM CVID was applied to measure the proportion of N-type 
current. A representative time plot from a neuron not exposed to N/OFQ is also shown. Note 
that the rundown in Ica is comparable in both cells. N-type ICa proportions measured using 
300 nM CVID are also very similar in both cells. B, No change was observed in the 
proportion of N-type current in IB4- neurons smaller than 20 μm following desensitisation of 
ORL1R in response to 10 min agonist exposure. C, No change was observed in the 
proportion of N-type current in IB4- neurons smaller than 20 μm following incubation at 37⁰ 
C for 30 minutes with vehicle, N/OFQ (300 nM) or both N/OFQ and [Met5]-enkephalin (10 
μM). 
 
Figure 5 
A, percentage of inhibition of evoked EPSCs by N/OFQ (1 μM). A significantly higher 
inhibition was observed in lamina I neurons compared to lamina II inner (P = 0.025).  Inset, 
representative trace showing inhibition of an evoked EPSC in the dorsal horn by N/OFQ (1 
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μM).  B, representative traces showing inhibition of evoked EPSCs by CVID (1 μM) 
following a 30 minute incubation with vehicle or N/OFQ (10 μM). C, percentage of 
inhibition of evoked EPSCs by CVID (1 μM). No significant difference was seen between 
EPSCs recorded from lamina I and lamina II inner. Further, incubating the slices with  
N/OFQ (10 μM) for 30 minutes prior to recording did not affect the inhibition of EPSC 
amplitude by CVID. 
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